Brain-derived neurotrophic factor: findings in schizophrenia.

Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry. 2011;24(2):122-7. DOI: 10.1097/YCO.0b013e3283436eb7. PubMed PMID: 21248641.

BDNF in schizophrenia, depression and corresponding animal models.

Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10(4):345-52. DOI: 10.1038/sj.mp.4001637. PubMed PMID: 15655562.

Schizophrenia as a progressive brain disease.

van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS. Schizophrenia as a progressive brain disease. European Psychiatry. 2008;23(4):245-54. DOI: 10.1016/j.eurpsy.2007.10.013. PubMed PMID: 18513927.

The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms.

Toro CT, Hallak JE, Dunham JS, Leite JP, Sakamoto AC, Guarnieri R, et al. The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms. Epilepsia. 2007;48(12):2352-6. DOI: 10.1111/j.1528-1167.2007.01194.x. PubMed PMID: 17919302.

Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.

Ho B-C, Andreasen NC, Dawson JD, Wassink TH. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry. 2007;164(12):1890-9. DOI: 10.1176/appi.ajp.2007.05111903. PubMed PMID: 18056245; PubMed Central PMCID: PMC3062255.

Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.

Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatric Genetics. 2007;17(3):165-70. DOI: 10.1097/YPG.0b013e32801da2e2. PubMed PMID: 17417060.

Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.

Kheirollahi M, Kazemi E, Ashouri S. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies. Cell Mol Neurobiol. 2016;36(1):1-10. DOI: 10.1007/s10571-015-0229-z. PubMed PMID: 26134309.

The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: an updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls.

Zhao X, Huang Y, Chen K, Li D, Han C, Kan Q. The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: an updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls. Psychiatry Res. 2015;225(1-2):217-20. DOI: 10.1016/j.psychres.2014.11.015. PubMed PMID: 25468641.

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

Numata S, Ueno S-I, Iga J-ichi, Yamauchi K, Hongwei S, Ohta K, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett. 2006;401(1-2):1-5. DOI: 10.1016/j.neulet.2006.02.054. PubMed PMID: 16533563.

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.

Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci. 2006;60(1):70-6. DOI: 10.1111/j.1440-1819.2006.01462.x. PubMed PMID: 16472361.